Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Rx.com

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rx.com head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 69 · Grade C

Rx.com

Visit Rx.com Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 78 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Rx.com a bad call — it's best for patients comparing a monthly purchase with annual prepayment who want named clinical and pharmacy partners. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
88
Supply Reliability
95
82
Transparency
90
76
Access Breadth
93
62
Clinical Oversight
92
78
Track Record
88
74
CoreAge RxBrief Score 94 · 78Rx.com

Price, coverage & the tracker

CoreAge RxRx.com
Brief Score94/100 (A)78/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$175/mo month-to-month

Annual option: $1,188 upfront ($99/mo equivalent); no automatic renewal.

Full price details

$175/mo month-to-month; $1,188 paid upfront for 12 months ($99/mo equivalent); compounded injection

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$285/mo month-to-month

Annual option: $1,788 upfront ($149/mo equivalent); no automatic renewal.

Full price details

$285/mo month-to-month; $1,788 paid upfront for 12 months ($149/mo equivalent); compounded injection

CoverageUS only; restrictions by state, confirmed at intake47 states; excludes Alaska, Louisiana and Mississippi; additional visit requirements may apply
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Rx.com: Monthly plans are $175 for semaglutide and $285 for tirzepatide. The $99/$149 equivalents require $1,188/$1,788 upfront for twelve months.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.